139 related articles for article (PubMed ID: 16680017)
21. Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.
Antonioli L; Fornai M; Colucci R; Ghisu N; Da Settimo F; Natale G; Kastsiuchenka O; Duranti E; Virdis A; Vassalle C; La Motta C; Mugnaini L; Breschi MC; Blandizzi C; Del Taca M
J Pharmacol Exp Ther; 2007 Aug; 322(2):435-42. PubMed ID: 17488880
[TBL] [Abstract][Full Text] [Related]
22. Relationship between expression of tight junction-related molecules and perturbed epidermal barrier function in UVB-irradiated hairless mice.
Yamamoto T; Kurasawa M; Hattori T; Maeda T; Nakano H; Sasaki H
Arch Dermatol Res; 2008 Feb; 300(2):61-8. PubMed ID: 18064478
[TBL] [Abstract][Full Text] [Related]
23. Effect of n-3 polyunsaturated fatty acids on membrane microdomain localization of tight junction proteins in experimental colitis.
Li Q; Zhang Q; Zhang M; Wang C; Zhu Z; Li N; Li J
FEBS J; 2008 Feb; 275(3):411-20. PubMed ID: 18167140
[TBL] [Abstract][Full Text] [Related]
24. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier.
Kong J; Zhang Z; Musch MW; Ning G; Sun J; Hart J; Bissonnette M; Li YC
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G208-16. PubMed ID: 17962355
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase-9 and metalloproteinase-2 activity and expression is reduced by melatonin during experimental colitis.
Esposito E; Mazzon E; Riccardi L; Caminiti R; Meli R; Cuzzocrea S
J Pineal Res; 2008 Sep; 45(2):166-73. PubMed ID: 18429971
[TBL] [Abstract][Full Text] [Related]
26. Disruption of tight junctions during polymicrobial sepsis in vivo.
Li Q; Zhang Q; Wang C; Liu X; Li N; Li J
J Pathol; 2009 Jun; 218(2):210-21. PubMed ID: 19235836
[TBL] [Abstract][Full Text] [Related]
27. Amelioration of experimental colitis by thalidomide.
Kenet G; Wardi J; Avni Y; Aeed H; Shirin H; Zaidel L; Hershkoviz R; Bruck R
Isr Med Assoc J; 2001 Sep; 3(9):644-8. PubMed ID: 11574978
[TBL] [Abstract][Full Text] [Related]
28. Role of poly(ADP-ribose) glycohydrolase in the development of inflammatory bowel disease in mice.
Cuzzocrea S; Mazzon E; Genovese T; Crisafulli C; Min WK; Di Paola R; Muià C; Li JH; Malleo G; Xu W; Massuda E; Esposito E; Zhang J; Wang ZQ
Free Radic Biol Med; 2007 Jan; 42(1):90-105. PubMed ID: 17157196
[TBL] [Abstract][Full Text] [Related]
29. 5-Aminoisoquinolinone reduces colon injury by experimental colitis.
Cuzzocrea S; Mazzon E; Di Paola R; Genovese T; Patel NS; Muià C; Threadgill MD; De Sarro A; Thiemermann C
Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):464-73. PubMed ID: 15599708
[TBL] [Abstract][Full Text] [Related]
30. Localized colonic inflammation increases cytokine levels in distant small intestinal segments in the rat.
Barada KA; Mourad FH; Sawah SI; Khoury C; Safieh-Garabedian B; Nassar CF; Saadé NE
Life Sci; 2006 Oct; 79(21):2032-42. PubMed ID: 16904127
[TBL] [Abstract][Full Text] [Related]
31. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis.
Ramakers JD; Verstege MI; Thuijls G; Te Velde AA; Mensink RP; Plat J
J Clin Immunol; 2007 May; 27(3):275-83. PubMed ID: 17510806
[TBL] [Abstract][Full Text] [Related]
32. Consequences of increased vascular permeability induced by treatment of mice with 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and thalidomide.
Chung F; Liu J; Ching LM; Baguley BC
Cancer Chemother Pharmacol; 2008 Mar; 61(3):497-502. PubMed ID: 17473922
[TBL] [Abstract][Full Text] [Related]
33. DHA protects against experimental colitis in IL-10-deficient mice associated with the modulation of intestinal epithelial barrier function.
Zhao J; Shi P; Sun Y; Sun J; Dong JN; Wang HG; Zuo LG; Gong JF; Li Y; Gu LL; Li N; Li JS; Zhu WM
Br J Nutr; 2015 Jul; 114(2):181-8. PubMed ID: 26104043
[TBL] [Abstract][Full Text] [Related]
34. Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitis.
Cannarile L; Cuzzocrea S; Santucci L; Agostini M; Mazzon E; Esposito E; Muià C; Coppo M; Di Paola R; Riccardi C
Gastroenterology; 2009 Feb; 136(2):530-41. PubMed ID: 18996377
[TBL] [Abstract][Full Text] [Related]
35. Role of M-CSF-dependent macrophages in colitis is driven by the nature of the inflammatory stimulus.
Ghia JE; Galeazzi F; Ford DC; Hogaboam CM; Vallance BA; Collins S
Am J Physiol Gastrointest Liver Physiol; 2008 Mar; 294(3):G770-7. PubMed ID: 18202111
[TBL] [Abstract][Full Text] [Related]
36. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment.
Clark JA; Doelle SM; Halpern MD; Saunders TA; Holubec H; Dvorak K; Boitano SA; Dvorak B
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G938-49. PubMed ID: 16798726
[TBL] [Abstract][Full Text] [Related]
37. TNF-alpha is crucial for the development of mast cell-dependent colitis in mice.
Rijnierse A; Koster AS; Nijkamp FP; Kraneveld AD
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G969-76. PubMed ID: 16798721
[TBL] [Abstract][Full Text] [Related]
38. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
Liu LB; Xue YX; Liu YH; Wang YB
J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
[TBL] [Abstract][Full Text] [Related]
39. Synergistic effect of low-frequency ultrasound and low-dose bradykinin on increasing permeability of the blood-tumor barrier by opening tight junction.
Zhang Z; Xia C; Xue Y; Liu Y
J Neurosci Res; 2009 Aug; 87(10):2282-9. PubMed ID: 19326437
[TBL] [Abstract][Full Text] [Related]
40. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function.
Campbell M; Collery R; McEvoy A; Gardiner TA; Stitt AW; Brankin B
Curr Eye Res; 2006 Dec; 31(12):1033-45. PubMed ID: 17169842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
